spacer
home > pmps > spring 2018 > time is short
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Time Is Short

Serialisation of prescription medicines will become mandatory in the EU on 9 February 2019, resulting in new labelling requirements as a prerequisite for market access. Other countries and regions are already further ahead. Therefore, pharmaceutical manufacturers must promptly invest in suitable solutions. Simultaneously, late-stage customisation is becoming increasingly important due to continuously decreasing batch sizes. If both digital printing processes can be combined in one step, the opportunity to implement compliant and costoptimised production will arise.

The first logical step is considering where serialisation can most sensibly be performed in the production process. Is it:

  • During the offset printing of sheets for the later folding cartons?
  • In a contract packaging facility?
  • In special logistics centres?
  • In the packaging lines of pharma manufacturers?

The solution chosen by the company will depend on the existing infrastructure as well as several other factors.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Stefan Rowinski, Product Manager at Atlantic Zeiser’s pharma and packaging solutions division, specialises in the development and marketing of system solutions for serialisation, late-stage customisation, and track-and-trace applications. Additionally, his expertise includes a deep knowledge of processes and workflow in sensitive environments and data management solutions. Prior to his position as a product manager, Stefan spent years designing, implementing and planning one-stop solutions for product individualisation and headed the projects to implement these solutions. 
spacer
Stefan Rowinski
spacer
spacer
Print this page
Send to a friend
Privacy statement

White Papers

The Power of Execution in Clinical Research

Medpace

Medpace, long known for its excellence in conducting Phase I-IV studies on a global platform, is particularly noted for its therapeutic excellence. When that expertise is combined with operational precision, the results are nothing short of stellar. The Medpace full-service outsourcing approach – combined with therapeutic expertise, regulatory know how, and global presence – delivers clinical studies with an industry recognized track record.
More info >>

 
Industry Events

ASGCT 22nd Annual Meeting

29 April - 2 May 2019, Washington Hilton, Washington, D.C

The 2019 ASGCT Annual Meeting is expected to be the largest in Society history, eclipsing the mark set by the 2018 meeting just last year. Join more than 3,500 researchers, clinicians, advocates, and industry leaders in discovering the latest science and technology surrounding gene and cell therapy.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement